Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Pharming Group N.V. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 9 | 11 | +2 |
| Shares | 59.1K | 140.5K | +81.3K (+137.5%) |
| Value | $857.3K | $2.48M | +$1.62M (+189.5%) |
New holders (4)
Institutions that held Pharming Group N.V. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 20,385 | $360.2K | 0.00% |
| Citadel Advisors LLC | 17,690 | $312.6K | 0.00% |
| SmartHarvest Portfolios, LLC | 12,687 | $224.2K | 0.08% |
| UBS Group AG | 1 | $18 | 0.00% |
Sold out (2)
Institutions that held Pharming Group N.V. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Global Retirement Partners, LLC | 23 | $334 |
| SBI Securities Co., Ltd. | 2 | $29 |